Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,875 | 154 | 99.4% |
| Education | $11.71 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,174 | 129 | $0 (2024) |
| Amgen Inc. | $181.21 | 9 | $0 (2021) |
| Relievant Medsystems, Inc. | $152.22 | 2 | $0 (2023) |
| Insulet Corporation | $148.99 | 3 | $0 (2023) |
| Nevro Corp. | $90.63 | 2 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $71.09 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $38.55 | 2 | $0 (2023) |
| Corcept Therapeutics | $18.12 | 1 | $0 (2023) |
| Lilly USA, LLC | $11.71 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $338.14 | 25 | Novo Nordisk Inc ($176.42) |
| 2023 | $693.13 | 48 | Novo Nordisk Inc ($335.25) |
| 2022 | $204.20 | 21 | Novo Nordisk Inc ($192.49) |
| 2021 | $651.08 | 61 | Novo Nordisk Inc ($469.87) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: Endocrinology | ||||||
| 10/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Endocrinology | ||||||
| 09/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Endocrinology | ||||||
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: Endocrinology | ||||||
| 06/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Obesity | ||||||
| 05/22/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: Endocrinology | ||||||
| 04/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: Endocrinology | ||||||
| 03/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Diabetes | ||||||
| 03/16/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $66.85 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/16/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Spinal Cord Stimulator | ||||||
| 03/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: Diabetes | ||||||
| 02/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Diabetes | ||||||
| 02/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Diabetes | ||||||
| 01/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: Diabetes | ||||||
| 01/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 401 | 656 | $211,113 | $41,398 |
| 2022 | 4 | 289 | 505 | $164,757 | $32,458 |
| 2021 | 4 | 272 | 376 | $136,051 | $28,584 |
| 2020 | 2 | 160 | 195 | $52,527 | $13,262 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 447 | $162,915 | $31,423 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 79 | $20,300 | $4,129 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $15,360 | $3,277 | 21.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 57 | 86 | $8,722 | $1,800 | 20.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,816 | $769.20 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 359 | $133,907 | $26,120 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 70 | $17,920 | $3,904 | 21.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 36 | 62 | $7,750 | $1,409 | 18.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 14 | 14 | $5,180 | $1,026 | 19.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 194 | 294 | $107,962 | $23,008 | 21.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 50 | $12,563 | $2,611 | 20.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $10,716 | $2,000 | 18.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $4,810 | $965.38 | 20.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 143 | 178 | $48,594 | $12,530 | 25.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 17 | $3,933 | $732.05 | 18.6% |
About Scott Beauchamp
Scott Beauchamp is a Family healthcare provider based in Abilene, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2020. The National Provider Identifier (NPI) number assigned to this provider is 1386278521.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Scott Beauchamp has received a total of $1,887 in payments from pharmaceutical and medical device companies, with $338.14 received in 2024. These payments were reported across 155 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,875).
As a Medicare-enrolled provider, Beauchamp has provided services to 1,122 Medicare beneficiaries, totaling 1,732 services with total Medicare billing of $115,701. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Abilene, TX
- Active Since 02/26/2020
- Last Updated 02/27/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1386278521
Products in Payments
- Ozempic (Drug) $619.03
- Rybelsus (Drug) $305.41
- RYBELSUS (Drug) $183.28
- Repatha (Biological) $181.21
- Intracept (Device) $152.22
- Omnipod (Device) $148.99
- Senza (Device) $90.63
- t:slim X2 Insulin Pump with Control-IQ (Device) $71.09
- JARDIANCE (Drug) $38.55
- Wegovy (Drug) $25.72
- Korlym (Drug) $18.12
- Saxenda (Drug) $14.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Abilene
Sandra Flores, Np, NP
Family — Payments: $4,903
Teresa Sowa, Np-C, NP-C
Family — Payments: $4,749
Mrs. Kathryn Barton, Rn, Fnp-C, RN, FNP-C
Family — Payments: $4,681
Linda Larsen, Rn Np-C, RN NP-C
Family — Payments: $4,675
Holly Mansur, Fnp-C, FNP-C
Family — Payments: $4,086
Rachel Brown, Aprn Fnp-C, APRN FNP-C
Family — Payments: $3,511